RecruitingPhase 3NCT06919614

STI Testing to Enhance PrEP Use in Pregnancy

Improving PrEP Outcomes Among Pregnant Women in Botswana With an Integrated STI Testing and PrEP Delivery Model


Sponsor

Botswana Harvard AIDS Institute Partnership

Enrollment

600 participants

Start Date

Jun 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators are conducting a study in Botswana to see if offering STI testing along with expanded HIV prevention options (PrEP) helps more pregnant women start and continue using PrEP during and after pregnancy. Pregnant women (n=600) seeking antenatal care in Botswana will be enrolled and randomly assigned to receive the standard of care (standard STI assessment with no STI testing) versus STI testing for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis during pregnancy and postpartum. The investigators' hypothesis is that providing STI testing alongside PrEP offer will encourage more women to start and continue using PrEP.


Eligibility

Sex: FEMALE

Inclusion Criteria7

  • Pregnant and seeking antenatal care
  • Self-identifying as a cis-gender woman
  • Living without HIV
  • Not currently using PrEP
  • Planning to remain in the city/town of enrolment until 9 months post-delivery.
  • Planning to receive antenatal and postnatal care in the city/town of enrolment.
  • Willing and able to provide informed consent

Exclusion Criteria7

  • Male gender
  • Not pregnant
  • Living with HIV
  • Currently using PrEP
  • Not planning to remain in the city/town of enrolment until 9 months post-delivery
  • Not planning to receive antenatal and postnatal care in the city/town to enrolment
  • Not able or willing to provide informed consent for participation

Interventions

DIAGNOSTIC_TESTChlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing

Xpert® CT/NG and TV testing


Locations(1)

DHMT Clinics

Gaborone, Botswana

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06919614


Related Trials